
EX-10.1
2
d687881dex101.htm
EX-10.1

EX-10.1

Exhibit 10.1 
Execution Version  CREDIT AGREEMENT
 Dated as of January 7, 2019 
among  COHERUS BIOSCIENCES, INC.,
 as the Borrower,  CERTAIN
DOMESTIC SUBSIDIARIES OF THE BORROWER,  as the Guarantors, 
HCR COLLATERAL MANAGEMENT, LLC, 
as the Administrative Agent  and
 THE LENDERS FROM TIME TO TIME PARTY HERETO 




TABLE OF CONTENTS   










 
    
 
  
Page
 

 ARTICLE I DEFINITIONS AND ACCOUNTING TERMS
  
 
1
 





 1.01
    
Defined Terms
  
 
1
 

 1.02
    
Other Interpretive Provisions
  
 
27
 

 1.03
    
Accounting Terms
  
 
28
 

 1.04
    
Illegality
  
 
29
 

 1.05
    
Inability to Determine Rates
  
 
29
 

 1.06
    
Times of Day
  
 
29
 




 ARTICLE II THE COMMITMENTS
  
 
30
 





 2.01
    
Term Loan Commitments
  
 
30
 

 2.02
    
Borrowings
  
 
30
 

 2.03
    
Prepayments
  
 
30
 

 2.04
    
Repayment of Loans
  
 
32
 

 2.05
    
Interest
  
 
33
 

 2.06
    
Fees
  
 
33
 

 2.07
    
Computation of Interest
  
 
33
 

 2.08
    
Evidence of Debt
  
 
33
 

 2.09
    
Payments Generally
  
 
34
 

 2.10
    
Sharing of Payments by Lenders
  
 
34
 

 2.11
    
Defaulting Lenders
  
 
35
 

 2.12
    
Termination of Term Loan Commitments
  
 
36
 




 ARTICLE III TAXES
  
 
36
 





 3.01
    
Taxes
  
 
36
 

 3.02
   

 
 
66
 

 8.03
    
Indebtedness
  
 
67
 

 8.04
    
Fundamental Changes
  
 
70
 

 8.05
    
Dispositions
  
 
70
 

 8.06
    
Restricted Payments
  
 
70
 

 8.07
    
Change in Nature of Business
  
 
71
 

 8.08
    
Transactions with Affiliates and Insiders
  
 
71
 

 8.09
    
Burdensome Agreements
  
 
71
 
  ii 














 8.10
    
Use of Proceeds
  
 
71
 

 8.11
    
Prepayment of Other Indebtedness
  
 
72
 

 8.12
    
Organization Documents; Fiscal Year; Legal Name, State of Formation and Form of Entity; Certain Amendments
  
 
72
 

 8.13
    
Ownership of Subsidiaries
  
 
72
 

 8.14
    
Sale Leasebacks
  
 
73
 

 8.15
    
Sanctions; Anti-Corruption Laws
  
 
73
 

 8.16
    
Liquidity
  
 
73
 

 8.17
    
Minimum Consolidated Net Sales
  
 
73
 




 ARTICLE IX EVENTS OF DEFAULT AND REMEDIES
  
 
73
 





 9.01
    
Events of Default
  
 
73
 

 9.02
    
Remedies Upon Event of Default
  
 
76
 

 9.03
    
Application of Funds
  
 
77
 




 ARTICLE X ADMINISTRATIVE AGENT
  
 
78
 





 10.01
    
Appointment and Authority
  
 
78
 

 10.02
    
Rights as a Lender
  
 
78
 

 10.03
    
Exculpatory Provisions
  
 
78
 

 10.04
    
Reliance by Administrative Agent
  
 
79
 

 10.05
    
Delegation of Duties
  
 
80
 

 10.06
    
Resignation of Administrative Agent
  
 
80
 

 10.07
    
Non-Reliance on Administrative Agent and Other Lenders
  
 
81
 

 10.08
    
Administrative Agent May File Proofs of Claim
  
 
81
 

 10.09
    
Collateral and Guaranty Matters
  
 
82
 




 ARTICLE XI MISCELLANEOUS
  
 
83
 





 11.01
    
Amendments, Etc.
  
 
83
 

 11.02
    
Notices and Other Communications; Facsimile Copies
  
 
84
 

 11.03
    
No Waiver; Cumulative Remedies; Enforcement
  
 
85
 

 11.04
    
Expenses; Indemnity; and Damage Waiver
  
 
86
 

 11.05
    
Payments Set Aside
  
 
87
 

 11.06
    
Successors and Assigns
  
 
88
 

 11.07
    
Treatment of Certain Information; Confidentiality
  
 
90
 

 11.08
    
Set-off
  
 
91
 

 11.09


   
Acknowledgement and Consent to Bail-In of EEA Financial Institutions
  
 
95
 

  iii 




SCHEDULES   






 1.01
    
Products

 2.01
    
Term Loan Commitments and Applicable Percentages

 6.10
    
Insurance

 6.13(a)
    
Subsidiaries

 6.13(b)
    
Capitalization

 6.17
    
IP Rights

 6.20(a)
    
Locations of Real Property

 6.20(b)
    
Taxpayer and Organizational Identification Numbers

 6.20(c)
    
Changes in Legal Name, State of Organization and Structure

 6.22
    
Material Contracts

 8.01
    
Liens Existing on the Closing Date

 8.02
    
Investments Existing on the Closing Date

 8.03
    
Indebtedness Existing on the Closing Date

 11.02
    
Certain Addresses for Notices




EXHIBITS
    





 A
    
Form of Loan Notice

 B
    
Form of Term Note

 C
    
Form of Joinder Agreement

 D
    
Form of Assignment and Assumption

 E
    
Form of Compliance Certificate
  
  iv 




CREDIT AGREEMENT 
This CREDIT AGREEMENT is entered into as of January 7, 2019 among COHERUS BIOSCIENCES, INC., a Delaware corporation (the
Borrower), the Guarantors (defined herein), the Lenders (defined herein) and HCR COLLATERAL MANAGEMENT, LLC, as Administrative Agent. 
The Borrower has requested that the Lenders make an investment in the Borrower in the form of a term loan facility, and the Lenders are
willing to do so on the terms and conditions set forth herein.  In consideration of the mutual covenants and agreements herein contained,
the parties hereto covenant and agree as follows:  ARTICLE I 
DEFINITIONS AND ACCOUNTING TERMS 
1.01    Defined Terms. 
As used in this Agreement, the following terms shall have the meanings set forth below: 
Acquisition means, with respect to any Person, the acquisition by such Person, in a single transaction or in a series of
related transactions, of (a) assets of another Person which constitute all or substantially all of the assets of such Person, or of any division, line of business or other business unit of such Person, (b) at least a majority of the Voting
Stock of another Person, in each case whether or not involving a merger or consolidation with such other Person and whether fo

le,
permit, lease, license, contract or other instrument, to the extent sufficient to permit any such item to become Collateral, a security interest in such general intangible, permit, lease, license, contract or other instrument shall be automatically
and simultaneously granted under the applicable Collateral Document and such general intangible, permit, lease, license, contract or other instrument shall no longer constitute Excluded Property and shall be considered Collateral,
(f) any leasehold interest of any Loan Party in real property, and (g) Deposit Accounts pledged in connection with Liens permitted by Section 8.01(r). 
Existing Convertible Notes means the 8.2% convertible senior notes due 2022 initially issued by the Borrower pursuant to
the Existing Convertible Note Purchase Agreement, including the guarantees thereof.  Existing Convertible Note Purchase
Agreement means that certain Convertible Note Purchase Agreement, dated as of February 29, 2016, among the Borrower, HealthCare Royalty Partners III, L.P., MX II Associates LLC, KMG Capital Partners, LLC and KKR Biosimilar L.P., each
as an investor, and the guarantors party thereto as amended by that certain Amendment thereto, dated March 25, 2016, as may hereafter be further amended or modified from time to time in accordance with the terms thereof. 
Exploitation shall mean, with respect to any Product, (a) any and all activities directed to the marketing, promotion,
distribution, offering for sale, selling, and other commercialization of such Product for the approved use; (b) importing and exporting such Product for sale; and (c) interacting with applicable Governmental Authorities regarding the
foregoing. When used as a verb, the term Exploit shall mean to engage in Exploitation. 
  10. 




Extraordinary Receipts means any cash received by or paid to or for the
account of any Person not in the ordinary course of business, including pension plan reversions, proceeds of insurance (other than proceeds of business interruption insurance to the extent such proceeds constitute compensation for lost earnings),
condemnation aw

y 1, 2020 and (b) the LIBOR Rate as of such date. 
Interim Financial Statements means the unaudited consolidated financial statements of the Borrower and its Subsidiaries for
the fiscal quarter ended September 30, 2018, including balance sheets and statements of income or operations, shareholders equity and cash flows. 
  14. 




Internal Revenue Code means the United States Internal Revenue Code of
1986.  Internal Revenue Service means the United States Internal Revenue Service. 
Investment means, as to any Person, any direct or indirect acquisition or investment by such Person, whether by means of
(a) the purchase or other acquisition of Equity Interests of another Person, (b) a loan, advance or capital contribution to, Guarantee or assumption of debt of, or purchase or other acquisition of any other debt or equity participation or
interest in, another Person, including any partnership or joint venture interest in such other Person and any arrangement pursuant to which the investor Guarantees Indebtedness of such other Person, or (c) an Acquisition. For purposes of
covenant compliance, the amount of any Investment shall be the amount actually invested, without adjustment for subsequent increases or decreases in the value of such Investment. 
Involuntary Disposition means any loss of, damage to or destruction of, or any condemnation or other taking for public use
of, any property of any Loan Party or any of its Subsidiaries.  IP Rights means, collectively, all Confidential
Information, all Copyrights, all Copyright Licenses, all Domain Names, all Governmental Licenses, all applications and requests for Governmental Licenses, all Other Intellectual Property, all Other IP Agreements, all Patents, all Patent Licenses,
all Proprietary Databases, all Proprietary Software, all Trademarks, all Trademark Licenses, all Trade Secrets, all Websites, all Website Agreements and all Regulatory Approvals. 
Joinder Agreement means a joinder agreement substantially in the f

er arising and shall be binding upon each Guarantor and its successors and assigns, and each Guarantor irrevocably waives (to the fullest extent permitted by law) any right (including without limitation any such right arising under
California Civil Code Section 2815) to revoke the guarantee in this Article IV as to future transactions giving rise to any Obligations. 
ARTICLE V  CONDITIONS PRECEDENT TO
CLOSING AND BORROWINGS  5.01 Conditions of Initial Borrowing. 
This Agreement shall become effective upon and the obligation of each Lender to make its portion of the Term Loan to be advanced on the
Closing Date hereunder is subject to satisfaction of the following conditions precedent:  (a) Loan Documents.
Receipt by the Administrative Agent of executed counterparts (include by electronic means) of this Agreement and the other Loan Documents, each executed (in a manner reasonably acceptable to the Administrative Agent) by a Responsible Officer of the
signing Loan Party.  (b) Opinions of Counsel. Receipt by the Administrative Agent a written legal opinion of
Latham & Watkins LLP, addressed to the Administrative Agent and each Lender as of the Closing Date, dated the Closing Date and in form and substance satisfactory to the Administrative Agent. 
  41. 




(c) Financial Statements. The Administrative Agent shall have
received the Audited Financial Statements, the Interim Financial Statements and such other reports, statements and due diligence items as the Administrative Agent or any Lender shall request. 
(d) No Material Adverse Effect. There shall not have occurred since December 31, 2017 any event or condition that
has had or could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect.  (e)
Litigation. There shall not exist any action, suit, investigation or proceeding pending or threatened in any court or before an arbitrator or Governmental Authority that could reasonably be expected, either individually or in the aggregate,
to have a Material Adverse Effect.  (f) Organization Documents, Resolutions, Etc. Rec

e Obligations,
in view of the impracticability and extreme difficulty of ascertaining actual damages and by mutual agreement of the parties as to a reasonable calculation of each Lenders lost profits as a result thereof. Any prepayment premium required by
Section 2.03(e) and any exit fee required by Section 2.06(b) payable pursuant to the preceding sentence shall be presumed to be the liquidated damages sustained by each Lender as the result of the
early termination and the Borrower agrees that it is reasonable under the circumstances currently existing. The prepayment premium required by Section 2.03(e) and the exit fee required by
Section 2.06(b) shall also be payable and any discount on the Term Loan shall be deemed earned in full, in each case, in the event that the Obligations (and/or this Agreement) are satisfied or released by foreclosure
(whether by power of judicial proceeding), deed in lieu of foreclosure or by any other means. TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE BORROWER EXPRESSLY WAIVES THE PROVISIONS OF ANY PRESENT OR FUTURE STATUTE OR LAW THAT PROHIBITS OR MAY
PROHIBIT THE COLLECTION OF THE FOREGOING 
  76. 





PREPAYMENT PREMIUM, EXIT FEE AND ANY DISCOUNT ON THE TERM LOAN IN CONNECTION WITH ANY SUCH ACCELERATION. The Borrower expressly agrees that (i) the prepayment premium required by
Section 2.03(e), the exit fee required by Section 2.06(b) and any discount on the Term Loan provided for herein is reasonable and is the product of an arms length transaction between sophisticated business
people, ably represented by counsel, (ii) the prepayment premium required by Section 2.03(e), the exit fee required by Section 2.06(b) and any discount on the Term Loan shall be payable
notwithstanding the then prevailing market rates at the time payment is made, (iii) there has been a course of conduct between the Lenders and the Borrower giving specific consideration in this transaction for such agreement to pay the
prepayment premium required by Section 2.03

principal, interest,
prepayment premium and exit fees) payable to the Lenders (including fees, charges and disbursements of counsel to the respective Lenders) arising under the Loan Documents and amounts payable under Article III, ratably among them in proportion
to the respective amounts described in this clause Second payable to them;  Third, to payment of that portion of the Obligations
constituting accrued and unpaid interest on and prepayment premium and exit fees with respect to the Loans, ratably among the Lenders in proportion to the respective amounts described in this clause Third held by them; 
Fourth, to payment of that portion of the Obligations constituting accrued and unpaid principal of the Loans, ratably among the Lenders in
proportion to the respective amounts described in this clause Fourth held by them; and  Last, the balance, if any, after all of the
Obligations have been paid in full in cash, to the Borrower or as otherwise required by Law. 
  77. 




ARTICLE X 
ADMINISTRATIVE AGENT  10.01
Appointment and Authority.  (a) Each of the Lenders hereby irrevocably appoints HCR Collateral Management, LLC to
act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the
terms hereof or thereof, together with such actions and powers as are incidental thereto. Except for the Borrowers specific rights contained in Section 10.06, the provisions of this Article are solely for the benefit
of the Administrative Agent and the Lenders, and neither the Borrower nor any other Loan Party shall have rights as a third party beneficiary of any of such provisions. It is understood and agreed that the use of the term agent
herein or in any other Loan Documents (or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obli

uch assignors Loans on the effective date of
such assignment;  (c) such assignment does not conflict with applicable Laws; and 
(d) a Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such
Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply. 
  92. 




11.14 Governing Law; Jurisdiction; Etc. 
(a) GOVERNING LAW. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS (EXCEPT, AS TO ANY OTHER LOAN DOCUMENT, AS EXPRESSLY SET
FORTH THEREIN) AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT (EXCEPT, AS TO ANY OTHER LOAN DOCUMENT, AS
EXPRESSLY SET FORTH THEREIN) AND THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 
(b) SUBMISSION TO JURISDICTION. THE BORROWER AND EACH OTHER LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT IT
WILL NOT COMMENCE ANY ACTION, LITIGATION OR PROCEEDING OF ANY KIND OR DESCRIPTION, WHETHER IN LAW OR EQUITY, WHETHER IN CONTRACT OR IN TORT OR OTHERWISE, AGAINST THE ADMINISTRATIVE AGENT, ANY LENDER OR ANY RELATED PARTY OF THE FOREGOING IN ANY WAY
RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS RELATING HERETO OR THERETO, IN ANY OTHER FORUM OTHER THAN THE COURTS OF THE STATE OF NEW YORK AND ANY UNITED STATES DISTRICT COURT IN THE STATE OF NEW YORK, AND ANY APPELLATE
COURT FROM ANY THEREOF LOCATED IN NEW YORK COUNTY, NEW YORK, AND EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY SUBMITS TO THE JURISDICTION OF SUCH COURTS AND AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION, LITIGATION OR PROCEEDING
MAY BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND
MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT OR IN ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT THE ADMINISTRATIVE AGENT OR ANY LENDER MAY OTHERWISE HAVE TO
BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST THE BORROWER OR ANY OTHER LOAN PARTY OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION. 
(c) WAIVER OF VENUE. THE BORROWER AND EACH OTHER LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT IN ANY COURT REFERRED TO IN PARAGRAPH
(B) OF THIS SECTION. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT. 
(d) SERVICE OF PROCESS. EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN
SECTION 11.02. NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY APPLICABLE LAW. 
  93. 




11.15 Waiver of Right to Trial by Jury. 
EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN
ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO
(A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. 
11.16 Electronic Execution of Assignments and Certain Other Documents. 
The words execute, execution, signed, signature and words of like import in any Assignment and
Assumption or in any amendment or other modification hereof (including waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by
the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use

ich may be payable to it by any Lender that is an EEA Financial Institution; and (b) the effects of any Bail-In Action on any such
liability, including, if applicable: (i) a reduction in full or in part or cancellation of any such liability; (ii) a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial
Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such
liability under this Agreement or any other Loan Document; or (iii) the variation of the terms of such liability in connection with the exercise of the write-down and conversion powers of any EEA Resolution Authority. 
[SIGNATURE PAGES FOLLOW] 
  95. 




IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first above written.   










BORROWER:
 

 
COHERUS BIOSCIENCES, INC.,a Delaware corporation







 

 
By:
 
/s/ Dennis M. Lanfear


 

 
Name: Dennis M. Lanfear


 

 
Title: President and Chief Executive Officer
  










GUARANTORS:
 

 
COHERUS INTERMEDIATE CORP.,a Delaware corporation







 

 
By:
 
/s/ Dennis M. Lanfear


 

 
Name: Dennis M. Lanfear


 

 
Title: President and Chief Executive Officer
  











 

 
INTEKRIN THERAPEUTICS INC.,a Delaware corporation







 

 
By:
 
/s/ Michael Fleming


 

 
Name: Michael Fleming


 

 
Title: President















ADMINISTRATIVE AGENT:
 

 
HCR COLLATERAL MANAGEMENT, LLC







 

 
By:
 
/s/ Clarke B. Futch


 

 
Name: Clarke B. Futch


 

 
Title: Managing Partner















LENDERS:
 

 
HEALTHCARE ROYALTY PARTNERS III, L.P.,a Delaware limited partnership






 

 
By: HealthCare Royalty GP III, LLC, its general partner







 

 
By:
 
/s/ Clarke B. Futch


 

 
Name: Clarke B. Futch


 

 
Title: Managing Partner
  











 

 
HCRP OVERFLOW FUND, L.P.,a Delaware limited partnership






 

 
By: HCRP Overflow GP, LLC, its general partner







 

 
By:
 
/s/ Clarke B. Futch


 

 
Name: Clarke B. Futch


 

 
Title: Managing Partner
  











 

 
HCR MOLAG FUND, L.P.,a Delaware limited partnership






 

 
By: HCR Molag Fund GP, LLC, its General Partner







 

 
By:
 
/s/ Clarke B. Futch


 

 
Name: Clarke B. Futch


 

 
Title: Managing Partner





[Schedule of Exceptions] 




EXHIBIT A 
FORM OF LOAN NOTICE 




EXHIBIT B 
FORM OF TERM NOTE 




EXHIBIT C 
FORM OF JOINDER AGREEMENT 




EXHIBIT D 
FORM OF ASSIGNMENT AND ASSUMPTION 




EXHIBIT E 
FORM OF COMPLIANCE CERTIFICATE 




